Literature DB >> 33519770

Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms.

Katharina Hoenes1, Richard Bauer2, Tobias Meurle1, Barbara Spellerberg2, Martin Hessling1.   

Abstract

Due to the globally observed increase in antibiotic resistance of bacterial pathogens and the simultaneous decline in new antibiotic developments, the need for alternative inactivation approaches is growing. This is especially true for the treatment of infections with the problematic ESKAPE pathogens, which include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, and often exhibit multiple antibiotic resistances. Irradiation with visible light from the violet and blue spectral range is an inactivation approach that does not require any additional supplements. Multiple bacterial and fungal species were demonstrated to be sensitive to this disinfection technique. In the present study, pathogenic ESKAPE organisms and non-pathogenic relatives are irradiated with visible blue and violet light with wavelengths of 450 and 405 nm, respectively. The irradiation experiments are performed at 37°C to test a potential application for medical treatment. For all investigated microorganisms and both wavelengths, a decrease in colony forming units is observed with increasing irradiation dose, although there are differences between the examined bacterial species. A pronounced difference can be observed between Acinetobacter, which prove to be particularly light sensitive, and enterococci, which need higher irradiation doses for inactivation. Differences between pathogenic and non-pathogenic bacteria of one genus are comparatively small, with the tendency of non-pathogenic representatives being less susceptible. Visible light irradiation is therefore a promising approach to inactivate ESKAPE pathogens with future fields of application in prevention and therapy.
Copyright © 2021 Hoenes, Bauer, Meurle, Spellerberg and Hessling.

Entities:  

Keywords:  405 nm; 450 nm; ESKAPE pathogens; antimicrobial blue light; non-pathogen; photoinactivation; visible light irradiation

Year:  2021        PMID: 33519770      PMCID: PMC7838345          DOI: 10.3389/fmicb.2020.612367

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  6 in total

1.  Blue light inactivation of the enveloped RNA virus Phi6.

Authors:  Petra Vatter; Katharina Hoenes; Martin Hessling
Journal:  BMC Res Notes       Date:  2021-05-17

2.  Photoinactivation of Staphylococci with 405 nm Light in a Trachea Model with Saliva Substitute at 37 °C.

Authors:  Tobias Meurle; Johannes Knaus; Agustin Barbano; Katharina Hoenes; Barbara Spellerberg; Martin Hessling
Journal:  Healthcare (Basel)       Date:  2021-03-11

3.  The effects of violet and blue light irradiation on ESKAPE pathogens and human cells in presence of cell culture media.

Authors:  Richard Bauer; Katharina Hoenes; Tobias Meurle; Martin Hessling; Barbara Spellerberg
Journal:  Sci Rep       Date:  2021-12-28       Impact factor: 4.379

Review 4.  Development and Research Progress of Anti-Drug Resistant Bacteria Drugs.

Authors:  Xiangyi Cui; Yuhong Lü; Changwu Yue
Journal:  Infect Drug Resist       Date:  2021-12-21       Impact factor: 4.003

5.  Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?

Authors:  Aleksandra Rapacka-Zdonczyk; Agata Wozniak; Beata Kruszewska; Krzysztof Waleron; Mariusz Grinholc
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

6.  Microbial Photoinactivation by Visible Light Results in Limited Loss of Membrane Integrity.

Authors:  Katharina Hoenes; Richard Bauer; Barbara Spellerberg; Martin Hessling
Journal:  Antibiotics (Basel)       Date:  2021-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.